Technical analysis of Abeona Therapeutics Inc. (ABEO): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its leading program, EB-101, an autologous gene-corrected cell therapy, is presently in a Phase III clinical trial for treating recessive dystrophic epidermolysis bullosa.
Price
| Price | $5.37 |
| Market Cap | $306M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 2.39 |
| EV / EBITDA | -3.81 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.16 |
| Current Ratio | 6.63 |
Explore sector: Healthcare · Biotechnology
More sections of ABEO: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks